Top studies of 2023 relevant to primary care: From the PEER team
CONCLUSION: Research published in 2023 yielded several high-quality articles with topics relevant to primary care, including cardiovascular care, irritable bowel syndrome, care of the elderly, and acne management.PMID:38626998 | DOI:10.46747/cfp.7004245 (Source: Canadian Family Physician Medecin de Famille Canadien)
Source: Canadian Family Physician Medecin de Famille Canadien - April 16, 2024 Category: Primary Care Authors: Betsy S Thomas Danielle Perry Samantha S Moe Ricky D Turgeon Jen Potter Émélie Braschi Nicholas Dugr é Jessica E M Kirkwood G Michael Allan Source Type: research
Top studies of 2023 relevant to primary care: From the PEER team
CONCLUSION: Research published in 2023 yielded several high-quality articles with topics relevant to primary care, including cardiovascular care, irritable bowel syndrome, care of the elderly, and acne management.PMID:38626998 | DOI:10.46747/cfp.7004245 (Source: Canadian Family Physician Medecin de Famille Canadien)
Source: Canadian Family Physician Medecin de Famille Canadien - April 16, 2024 Category: Primary Care Authors: Betsy S Thomas Danielle Perry Samantha S Moe Ricky D Turgeon Jen Potter Émélie Braschi Nicholas Dugr é Jessica E M Kirkwood G Michael Allan Source Type: research
Top studies of 2023 relevant to primary care: From the PEER team
CONCLUSION: Research published in 2023 yielded several high-quality articles with topics relevant to primary care, including cardiovascular care, irritable bowel syndrome, care of the elderly, and acne management.PMID:38626998 | DOI:10.46747/cfp.7004245 (Source: Canadian Family Physician Medecin de Famille Canadien)
Source: Canadian Family Physician Medecin de Famille Canadien - April 16, 2024 Category: Primary Care Authors: Betsy S Thomas Danielle Perry Samantha S Moe Ricky D Turgeon Jen Potter Émélie Braschi Nicholas Dugr é Jessica E M Kirkwood G Michael Allan Source Type: research
Top studies of 2023 relevant to primary care: From the PEER team
CONCLUSION: Research published in 2023 yielded several high-quality articles with topics relevant to primary care, including cardiovascular care, irritable bowel syndrome, care of the elderly, and acne management.PMID:38626998 | DOI:10.46747/cfp.7004245 (Source: Canadian Family Physician Medecin de Famille Canadien)
Source: Canadian Family Physician Medecin de Famille Canadien - April 16, 2024 Category: Primary Care Authors: Betsy S Thomas Danielle Perry Samantha S Moe Ricky D Turgeon Jen Potter Émélie Braschi Nicholas Dugr é Jessica E M Kirkwood G Michael Allan Source Type: research
Top studies of 2023 relevant to primary care: From the PEER team
CONCLUSION: Research published in 2023 yielded several high-quality articles with topics relevant to primary care, including cardiovascular care, irritable bowel syndrome, care of the elderly, and acne management.PMID:38626998 | DOI:10.46747/cfp.7004245 (Source: Canadian Family Physician Medecin de Famille Canadien)
Source: Canadian Family Physician Medecin de Famille Canadien - April 16, 2024 Category: Primary Care Authors: Betsy S Thomas Danielle Perry Samantha S Moe Ricky D Turgeon Jen Potter Émélie Braschi Nicholas Dugr é Jessica E M Kirkwood G Michael Allan Source Type: research
Top studies of 2023 relevant to primary care: From the PEER team
CONCLUSION: Research published in 2023 yielded several high-quality articles with topics relevant to primary care, including cardiovascular care, irritable bowel syndrome, care of the elderly, and acne management.PMID:38626998 | DOI:10.46747/cfp.7004245 (Source: Canadian Family Physician Medecin de Famille Canadien)
Source: Canadian Family Physician Medecin de Famille Canadien - April 16, 2024 Category: Primary Care Authors: Betsy S Thomas Danielle Perry Samantha S Moe Ricky D Turgeon Jen Potter Émélie Braschi Nicholas Dugr é Jessica E M Kirkwood G Michael Allan Source Type: research
Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo
AbstractTopical ruxolitinib 1.5% cream (Opzelura®), a Janus kinase (JAK) inhibitor, is the first treatment to be approved in several countries for use in patients aged ≥ 12 years with non-segmental vitiligo. In the identical phase III TRuE-V1 and TRuE-V2 trials, significantly more ruxolitinib cream recipients were able to achieve statistically significant and clinically meaningful facial and total body repigmentation, as well as reductions in vitiligo noticea bility, compared with vehicle recipients. Efficacy was sustained in longer-term analyses to week 104 of treatment. Ruxolitinib 1.5% cream was generally tolerabl...
Source: Drugs - April 16, 2024 Category: Drugs & Pharmacology Source Type: research
Molecules, Vol. 29, Pages 1793: Saponins of Paris polyphylla for the Improvement of Acne: Anti-Inflammatory, Antibacterial, Antioxidant and Immunomodulatory Effects
g
Quan An
Acne is a chronic inflammatory skin disease with a recurring nature that seriously impacts patients’ quality of life. Currently, antibiotic resistance has made it less effective in treating acne. However, Paris polyphylla (P. polyphylla) is a valuable medicinal plant with a wide range of chemical components. Of these, P. polyphylla saponins modulate the effects in vivo and in vitro through antibacterial, anti-inflammatory, immunomodulatory, and antioxidant effects. Acne is primarily associated with inflammatory reactions, abnormal sebum function, micro-ecological disorders, hair follicle hyper...
Source: Molecules - April 15, 2024 Category: Chemistry Authors: Luyao Li Jiachan Zhang Wenjing Cheng Feiqian Di Changtao Wang Quan An Tags: Review Source Type: research
Correlation between acne and insulin resistance; experience from central India
CONCLUSION: Our study suggests the prevalence of insulin resistance in 42.67% of patients with acne, thereby providing the possibility of use of insulin modifiers as an adjunct acne treatment and stratifying the possible risk of metabolic syndrome in patients with acne. Also recommended is the control of dietary factors and lifestyle modification for the management of acne with insulin resistance.PMID:38605790 | PMC:PMC11006054 | DOI:10.4103/jfmpc.jfmpc_1232_23 (Source: Primary Care)
Source: Primary Care - April 12, 2024 Category: Primary Care Authors: Prachi R Srivastava Jaideep Khare Animesh Saxena Sushil Jindal Source Type: research
Correlation between acne and insulin resistance; experience from central India
CONCLUSION: Our study suggests the prevalence of insulin resistance in 42.67% of patients with acne, thereby providing the possibility of use of insulin modifiers as an adjunct acne treatment and stratifying the possible risk of metabolic syndrome in patients with acne. Also recommended is the control of dietary factors and lifestyle modification for the management of acne with insulin resistance.PMID:38605790 | PMC:PMC11006054 | DOI:10.4103/jfmpc.jfmpc_1232_23 (Source: Primary Care)
Source: Primary Care - April 12, 2024 Category: Primary Care Authors: Prachi R Srivastava Jaideep Khare Animesh Saxena Sushil Jindal Source Type: research
Evaluation of Isotretinoin effects on depression, sleep apnea and sleep quality
Conclusion: This study showed that isotretinoin had no significant effects on depression and sleep quality.PMID:38608451 | DOI:10.1080/15569527.2024.2340435 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - April 12, 2024 Category: Toxicology Authors: Ozge Mine Orenay Berkay Temel Arcan Kivanc Capci Zulal Inci Bal Nermin Karaosmanoglu Source Type: research
Correlation between acne and insulin resistance; experience from central India
CONCLUSION: Our study suggests the prevalence of insulin resistance in 42.67% of patients with acne, thereby providing the possibility of use of insulin modifiers as an adjunct acne treatment and stratifying the possible risk of metabolic syndrome in patients with acne. Also recommended is the control of dietary factors and lifestyle modification for the management of acne with insulin resistance.PMID:38605790 | PMC:PMC11006054 | DOI:10.4103/jfmpc.jfmpc_1232_23 (Source: Primary Care)
Source: Primary Care - April 12, 2024 Category: Primary Care Authors: Prachi R Srivastava Jaideep Khare Animesh Saxena Sushil Jindal Source Type: research
Evaluation of Isotretinoin effects on depression, sleep apnea and sleep quality
Conclusion: This study showed that isotretinoin had no significant effects on depression and sleep quality.PMID:38608451 | DOI:10.1080/15569527.2024.2340435 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - April 12, 2024 Category: Toxicology Authors: Ozge Mine Orenay Berkay Temel Arcan Kivanc Capci Zulal Inci Bal Nermin Karaosmanoglu Source Type: research
Evaluation of isotretinoin effects on depression, sleep apnea and sleep quality
CONCLUSION: This study showed that isotretinoin had no significant effects on depression and sleep quality.PMID:38608451 | DOI:10.1080/15569527.2024.2340435 (Source: Cutaneous and Ocular Toxicology)
Source: Cutaneous and Ocular Toxicology - April 12, 2024 Category: Toxicology Authors: Ozge Mine Orenay Berkay Temel Arcan Kivanc Capci Zulal Inci Bal Nermin Karaosmanoglu Source Type: research
